{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:15:34Z","timestamp":1791087334996,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.vaccine.2005.07.002","type":"journal-article","created":{"date-parts":[[2005,7,19]],"date-time":"2005-07-19T14:28:06Z","timestamp":1121783286000},"page":"5205-5211","source":"Crossref","is-referenced-by-count":193,"title":["Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004"],"prefix":"10.1016","volume":"23","author":[{"given":"Joachim","family":"Hombach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kurane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.07.002_bib1","article-title":"Japanese encephalitis vaccines","author":"Halstead","year":"2003","journal-title":"Plotkin"},{"key":"10.1016\/j.vaccine.2005.07.002_bib2","unstructured":"Technical Report Series, http:\/\/www.who.int\/biologicals\/expert_committee\/en\/ (accessed 2-5-2005)."},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.002_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.235.1.31","article-title":"Booster vaccination with further live attenuated measles vaccine","volume":"235","author":"Bass","year":"1976","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2005.07.002_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1086\/517358","article-title":"Immunogenicity of live attenuated SA 14-14-2 Japanese encephalitis vaccine\u2014a comparison of 1- and 3-month immunization schedules","volume":"177","author":"Tsai","year":"1998","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2005.07.002_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1442-200X.1988.tb02516.x","article-title":"Japanese encephalitis vaccine","volume":"30","author":"Oya","year":"1988","journal-title":"Acta Paediatr Jpn"},{"issue":"4","key":"10.1016\/j.vaccine.2005.07.002_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4269\/ajtmh.1973.22.535","article-title":"Passive immunity for arbovirus infection. II. Quantitative aspects of naturally and artificially acquired protection in mice for Japanese (B) encephalitis virus","volume":"22","author":"Lubiniecki","year":"1973","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"10.1016\/j.vaccine.2005.07.002_bib7","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1128\/JVI.73.7.5527-5534.1999","article-title":"The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes","volume":"73","author":"Konishi","year":"1999","journal-title":"J Virol"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2005.07.002_bib8","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1016\/j.vaccine.2004.03.027","article-title":"Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine","volume":"22","author":"Beasley","year":"2004","journal-title":"Vaccine"},{"issue":"Pt 4","key":"10.1016\/j.vaccine.2005.07.002_bib9","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1099\/0022-1317-77-4-705","article-title":"Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells","volume":"77","author":"Murali-Krishna","year":"1996","journal-title":"J Gen Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2005.07.002_bib10","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","article-title":"Role of CD8+ T cells in control of West Nile virus infection","volume":"78","author":"Shrestha","year":"2004","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2005.07.002_bib11","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen","volume":"188","author":"Monath","year":"2003","journal-title":"J Infect Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2005.07.002_bib12","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0264-410X(03)00230-5","article-title":"Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants","volume":"21","author":"Jodar","year":"2003","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2005.07.002_bib13","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"N Engl J Med"},{"issue":"9015","key":"10.1016\/j.vaccine.2005.07.002_bib14","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(96)91075-2","article-title":"Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study","volume":"347","author":"Hennessy","year":"1996","journal-title":"Lancet"},{"issue":"9284","key":"10.1016\/j.vaccine.2005.07.002_bib15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(01)05967-0","article-title":"Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study","volume":"358","author":"Bista","year":"2001","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2005.07.002_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0264-410X(00)00038-4","article-title":"Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines","volume":"18","author":"Markoff","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.002_bib17","unstructured":"From Federal Register. vol. 67, no. 105; May 31, 2002. 21 CFR parts 314 and 601; http:\/\/www.gpoaccess.gov\/fr\/\/ (accessed 22.06.2005)."},{"key":"10.1016\/j.vaccine.2005.07.002_bib18","unstructured":"WHO guidelines on clinical evaluation of vaccines: regulatory expectations. http:\/\/whqlibdoc.who.int\/trs\/WHQ TRS 924 annexl.pdf (accessed 2-5-2005)."},{"issue":"18","key":"10.1016\/j.vaccine.2005.07.002_bib19","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/S0264-410X(99)00006-7","article-title":"Primary and booster immune responses to SA14-14-2 Japanese encephalitis vaccine in Korean infants","volume":"17","author":"Sohn","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.07.002_bib20","unstructured":"EMEA\/CPMP Note for guidance on clinical evaluation of new vaccines. http:\/\/www.emea.eu.int\/pdfs\/human\/ewp\/046397EN.pdf (accessed 14-12-2004)."},{"key":"10.1016\/j.vaccine.2005.07.002_bib21","unstructured":"Guidelines for the production and control of Japanese encephalitis vaccine (live)\u2014for human use. WHO TRS No 910, Annex 3. http:\/\/www.who.int\/biologicals\/publications\/trs\/en\/ (accessed 2-5-2005)."},{"key":"10.1016\/j.vaccine.2005.07.002_bib22","unstructured":"Requirements for Japanese encephalitis vaccine (inactivated) for human use WHO TRS No 771, Annex 6. http:\/\/www.who.int\/biologicals\/publications\/trs\/en\/ (accessed 2-5-2005)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05006389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05006389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T08:17:04Z","timestamp":1586333824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05006389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":22,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0264410X05006389"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.002","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}